491
Views
51
CrossRef citations to date
0
Altmetric
Review

Emergence and clinical insights into the pathology of Chikungunya virus infection

, , , , , , , & show all
Pages 987-996 | Published online: 10 Jan 2014

References

  • Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect. Dis.7, 319–327 (2007).
  • Jaffar-Bandjee MC, Das T, Hoarau JJ et al. Chikungunya virus takes centre stage in virally induced arthritis: possible cellular and molecular mechanisms to pathogenesis. Microbes Infect.11, 1206–1218 (2009).
  • Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution. Microbiol. Rev.58, 491–562 (1994).
  • Robinson MC. An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952–1953. I. Clinical features. Trans. R. Soc. Trop. Med. Hyg.49, 28–32 (1955).
  • Lemant J, Boisson V, Winer A et al. Serious acute Chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005–2006. Crit. Care Med.36, 2536–2541 (2008).
  • Mavalankar D, Shastri P, Raman P. Chikungunya epidemic in India: a major public-health disaster. Lancet Infect. Dis.7, 306–307 (2007).
  • Sissoko D, Malvy D, Ezzedine K et al. Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl. Trop. Dis.3, e389 (2009).
  • Ross RW. The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J. Hyg.54, 177–191 (1956).
  • Filipe AF, Pinto MR. Arbovirus studies in Luanda, Angola. 2. Virological and serological studies during an outbreak of dengue-like disease caused by the Chikungunya virus. Bull. World Health Organ.49, 37–40 (1973).
  • Ivanov AP, Ivanova OE, Lomonosov NN et al. Serological investigations of Chikungunya virus in the Republic of Guinea. Ann. Soc. Belg. Med. Trop.72, 73–74 (1992).
  • Moore DL, Reddy S, Akinkugbe FM et al. An epidemic of Chikungunya fever at Ibadan, Nigeria, 1969. Ann. Trop. Med. Parasitol.68, 59–68 (1974).
  • Guilherme JM, Gonella-Legall C, Legall F, Nakoume E, Vincent J. Seroprevalence of five arboviruses in Zebu cattle in the Central African Republic. Trans. R. Soc. Trop. Med. Hyg.90, 31–33 (1996).
  • McIntosh BM, Harwin RM, Paterson HE, Westwater ML. An epidemic of Chikungunya in south-eastern southern Rhodesia. Cent. Afr. J. Med.43, 351–359 (1963).
  • Mackenzie JS, Chua KB, Daniels PW et al. Emerging viral diseases of Southeast Asia and the Western Pacific. Emerg. Infect. Dis.7, 497–504 (2001).
  • Porter KR, Tan R, Istary Y et al. A serological study of Chikungunya virus transmission in Yogyakarta, Indonesia: evidence for the first outbreak since 1982. Southeast Asian J. Trop. Med. Public Health35, 408–415 (2004).
  • Rao TR. Immunological surveys of arbovirus infections in South-East Asia, with special reference to dengue, Chikungunya, and Kyasanur Forest disease. Bull. World Health Organ.44, 585–591 (1971).
  • Sergon K, Njuguna C, Kalani R et al. Seroprevalence of Chikungunya virus (CHIKV) infection on Lamu Island, Kenya, October 2004. Am. J. Trop. Med. Hyg.78, 333–337 (2008).
  • Sergon K, Yahaya AA, Brown J et al. Seroprevalence of Chikungunya virus infection on Grande Comore Island, union of the Comoros, 2005. Am. J. Trop. Med. Hyg.76, 1189–1193 (2007).
  • Gerardin P, Barau G, Michault A et al. Multidisciplinary prospective study of mother-to-child Chikungunya virus infections on the island of La Reunion. PLoS Med5, e60 (2008).
  • Renault P, Solet JL, Sissoko D et al. A major epidemic of Chikungunya virus infection on Reunion Island, France, 2005–2006. Am. J. Trop. Med. Hyg.77, 727–731 (2007).
  • Zheng K, Li J, Zhang Q et al. Genetic analysis of Chikungunya viruses imported to mainland China in 2008. Virol. J.7, 8 (2010).
  • Rezza G, Nicoletti L, Angelini R et al. Infection with Chikungunya virus in Italy: an outbreak in a temperate region. Lancet370, 1840–1846 (2007).
  • Powers AM, Brault AC, Tesh RB, Weaver SC. Re-emergence of Chikungunya and O’nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J. Gen. Virol.81, 471–479 (2000).
  • Powers AM, Logue CH. Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J. Gen. Virol.88, 2363–2377 (2007).
  • Kariuki Njenga M, Nderitu L, Ledermann JP et al. Tracking epidemic Chikungunya virus into the Indian Ocean from East Africa. J. Gen. Virol.89, 2754–2760 (2008).
  • Huang JH, Yang CF, Su CL et al. Imported Chikungunya virus strains, Taiwan, 2006–2009. Emerg. Infect. Dis.15, 1854–1856 (2009).
  • Parola P, de Lamballerie X, Jourdan J et al. Novel Chikungunya virus variant in travelers returning from Indian Ocean islands. Emerg. Infect. Dis.12, 1493–1499 (2006).
  • Moore CG, Mitchell CJ. Aedes albopictus in the United States: ten-year presence and public health implications. Emerg. Infect. Dis.3, 329–334 (1997).
  • Gould EA, Higgs S. Impact of climate change and other factors on emerging arbovirus diseases. Trans. R. Soc. Trop. Med. Hyg.103, 109–121 (2009).
  • Schuffenecker I, Iteman I, Michault A et al. Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med.3, e263 (2006).
  • Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog.3, e201 (2007).
  • Vazeille M, Moutailler S, Coudrier D et al. Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus. PLoS One2, e1168 (2007).
  • Kam YW, Ong EK, Renia L, Tong JC, Ng LF. Immuno-biology of Chikungunya and implications for disease intervention. Microbes Infect.11, 1186–1196 (2009).
  • Kumar NP, Joseph R, Kamaraj T, Jambulingam P. A226V mutation in virus during the 2007 Chikungunya outbreak in Kerala, India. J. Gen. Virol.89, 1945–1948 (2008).
  • Leo YS, Chow AL, Tan LK et al. Chikungunya outbreak, Singapore, 2008. Emerg. Infect. Dis.15, 836–837 (2009).
  • Robillard PY, Boumahni B, Gerardin P et al. [Vertical maternal fetal transmission of the Chikungunya virus. Ten cases among 84 pregnant women]. Presse Med.35, 785–788 (2006).
  • Ramful D, Carbonnier M, Pasquet M et al. Mother-to-child transmission of Chikungunya virus infection. Pediatr. Infect. Dis. J.26, 811–815 (2007).
  • Rao G, Khan YZ, Chitnis DS. Chikungunya infection in neonates. Ind. Pediatr.45, 240–242 (2008).
  • Senanayake MP, Senanayake SM, Vidanage KK, Gunasena S, Lamabadusuriya SP. Vertical transmission in Chikungunya infection. Ceylon Med. J.54, 47–50 (2009).
  • Samperiz E, Gerardin P, Noormahomed T, Beullier G, Boya I. [Perinatal transmission of Chikungunya virus infection: 47 cases from La Réunion Island]. Bull. Soc. Pathol. Exot. Filiales100, 355 (2007).
  • Ramful D, Fourmaintraux A, Rollot A et al. [Neurodevelopmental outcome at 2 years in children with materno-fetal Chikungunya virus infection]. Arch. Pediatr. Livre des Résumés17(6, Suppl. 1), 17 (2010).
  • Fritel X, Rollot O, Gerardin P et al. Chikungunya virus infection during pregnancy, Reunion, France, 2006. Emerg. Infect. Dis.16, 418–425 (2010).
  • Touret Y, Randrianaivo H, Michault A et al. [Early maternal–fetal transmission of the Chikungunya virus]. Presse Med.35, 1656–1658 (2006).
  • Couderc T, Chretien F, Schilte C et al. A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog.4, e29 (2008).
  • Grivard P, Le Roux K, Laurent P et al. Molecular and serological diagnosis of Chikungunya virus infection. Pathol. Biol. (Paris)55, 490–494 (2007).
  • Ernould S, Walters H, Alessandri JL et al. [Chikungunya in paediatrics: epidemic of 2005–2006 in Saint-Denis, Reunion Island]. Arch. Pediatr.15, 253–262 (2008).
  • Le Bomin A, Hebert JC, Marty P, Delaunay P. [Confirmed Chikungunya in children in Mayotte. Description of 50 patients hospitalized from February to June 2006]. Med. Trop. (Mars.)68, 491–495 (2008).
  • Valamparampil JJ, Chirakkarot S, Letha S, Jayakumar C, Gopinathan KM. Clinical profile of Chikungunya in infants. Ind. J. Pediatr.76, 151–155 (2009).
  • Robin S, Ramful D, Le Seach F et al. Neurologic manifestations of pediatric Chikungunya infection. J. Child Neurol.23, 1028–1035 (2008).
  • Lewthwaite P, Vasanthapuram R, Osborne JC et al. Chikungunya virus and central nervous system infections in children, India. Emerg. Infect. Dis.15, 329–331 (2009).
  • Couderc T, Khandoudi N, Grandadam M et al. Prophylaxis and therapy for Chikungunya virus infection. J. Infect. Dis.200, 516–523 (2009).
  • Borgherini G, Poubeau P, Staikowsky F et al. Outbreak of Chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin. Infect. Dis.44, 1401–1407 (2007).
  • Lakshmi V, Neeraja M, Subbalaxmi MV et al. Clinical features and molecular diagnosis of Chikungunya fever from South India. Clin. Infect. Dis.46, 1436–1442 (2008).
  • Her Z, Kam YW, Lin RT, Ng LF. Chikungunya: a bending reality. Microbes Infect.11, 1165–1176 (2009).
  • Osterrieth P, Deleplanque-Liegeois P, Renoirte R. [Research on the Chikungunya virus in the Belgian Congo. II. Serological investigation]. Ann. Soc. Belg. Med. Trop. (1920)40, 205–213 (1960).
  • Panning M, Grywna K, van Esbroeck M, Emmerich P, Drosten C. Chikungunya fever in travelers returning to Europe from the Indian Ocean region, 2006. Emerg. Infect. Dis.14, 416–422 (2008).
  • Hoarau JJ, Bandjee MC, Trotot PK et al. Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J. Immunol.184, 5914–5927 (2010).
  • Ng LF, Chow A, Sun YJ et al. IL-1β, IL-6, and RANTES as biomarkers of Chikungunya severity. PLoS One4, e4261 (2009).
  • Economopoulou A, Dominguez M, Helynck B et al. Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005–2006 outbreak on Reunion. Epidemiol. Infect.137, 534–541 (2009).
  • Mazaud R, Salaun JJ, Montabone H, Goube P, Bazillio R. [Acute neurologic and sensorial disorders in dengue and Chikungunya fever]. Bull. Soc. Pathol. Exot. Filiales64, 22–30 (1971).
  • Lebrun G, Chadda K, Reboux AH, Martinet O, Gauzere BA. Guillain–Barre syndrome after Chikungunya infection. Emerg. Infect. Dis.15, 495–496 (2009).
  • Wang E, Volkova E, Adams AP et al. Chimeric alphavirus vaccine candidates for Chikungunya. Vaccine26, 5030–5039 (2008).
  • Ziegler SA, Lu L, da Rosa AP, Xiao SY, Tesh RB. An animal model for studying the pathogenesis of Chikungunya virus infection. Am. J. Trop. Med. Hyg.79, 133–139 (2008).
  • Mahesh G, Giridhar A, Shedbele A, Kumar R, Saikumar SJ. A case of bilateral presumed Chikungunya neuroretinitis. Ind. J. Ophthalmol.57, 148–150 (2009).
  • Prashant S, Kumar AS, Basheeruddin DD, Chowdhary TN, Madhu B. Cutaneous manifestations in patients suspected of Chikungunya disease. Ind. J. Dermatol.54, 128–131 (2009).
  • Talarmin F, Staikowsky F, Schoenlaub P et al. [Skin and mucosal manifestations of Chikungunya virus infection in adults in Reunion Island]. Med. Trop. (Mars.)67, 167–173 (2007).
  • Tandale BV, Sathe PS, Arankalle VA et al. Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. J. Clin. Virol.46(2), 145–149 (2009).
  • Sankari T, Hoti SL, Govindaraj V, Das PK. Chikungunya and respiratory viral infections. Lancet Infect. Dis.8, 3–4 (2008).
  • de Andrade DC, Jean S, Clavelou P, Dallel R, Bouhassira D. Chronic pain associated with the Chikungunya fever: long lasting burden of an acute illness. BMC Infect. Dis.10, 31 (2010).
  • Soumahoro MK, Gerardin P, Boelle PY et al. Impact of Chikungunya virus infection on health status and quality of life: a retrospective cohort study. PLoS One4, e7800 (2009).
  • Tesh RB. Arthritides caused by mosquito-borne viruses. Annu. Rev. Med.33, 31–40 (1982).
  • Harley D, Sleigh A, Ritchie S. Ross River virus transmission, infection, and disease: a cross-disciplinary review. Clin. Microbiol. Rev.14, 909–932 (2001).
  • Levine B, Hardwick JM, Griffin DE. Persistence of alphaviruses in vertebrate hosts. Trends Microbiol.2, 25–28 (1994).
  • Suhrbier A, La Linn M. Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr. Opin. Rheumatol.16, 374–379 (2004).
  • Toivanen A. Alphaviruses: an emerging cause of arthritis? Curr. Opin. Rheumatol.20, 486–490 (2008).
  • Brighton SW, Simson IW. A destructive arthropathy following Chikungunya virus arthritis – a possible association. Clin. Rheumatol.3, 253–258 (1984).
  • Fourie ED, Morrison JG. Rheumatoid arthritic syndrome after Chikungunya fever. S. Afr. Med. J.56, 130–132 (1979).
  • Simon F, Parola P, Grandadam M et al. Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases. Medicine86, 123–137 (2007).
  • Borgherini G, Poubeau P, Jossaume A et al. Persistent arthralgia associated with Chikungunya virus: a study of 88 adult patients on Reunion island. Clin. Infect. Dis.47, 469–475 (2008).
  • Manimunda SP, Vijayachari P, Uppoor R et al. Clinical progression of Chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans. R. Soc. Trop. Med. Hyg.104, 392–399 (2010).
  • Chopra A, Anuradha V, Lagoo-Joshi V et al. Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum.58, 2921–2922 (2008).
  • Bouquillard E, Combe B. Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases. Ann. Rheum. Dis.68, 1505–1506 (2009).
  • Malvy D, Ezzedine K, Mamani-Matsuda M et al. Destructive arthritis in a patient with Chikungunya virus infection with persistent specific IgM antibodies. BMC Infect. Dis.9, 200 (2009).
  • Labadie K, Larcher T, Joubert C et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J. Clin. Invest.120, 894–906 (2010).
  • Sorge F. [Prevention with repellent in children]. Arch Pediatr.16(Suppl. 2), S115–S122 (2009).
  • Brighton SW. Chloroquine phosphate treatment of chronic Chikungunya arthritis. An open pilot study. S. Afr. Med. J.66, 217–218 (1984).
  • Maheshwari RK, Srikantan V, Bhartiya D. Chloroquine enhances replication of Semliki Forest virus and encephalomyocarditis virus in mice. J. Virol.65, 992–995 (1991).
  • de Lamballerie X, Ninove L, Charrel RN. Antiviral treatment of Chikungunya virus infection. Infect. Disord. Drug Targets9, 101–104 (2009).
  • Gardner J, Anraku I, Le TT et al. Chikungunya virus arthritis in adult wild-type mice. J. Virol.84(16), 8021–8032 (2010).
  • Malet H, Coutard B, Jamal S et al. The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J. Virol.83, 6534–6545 (2009).
  • Dash PK, Tiwari M, Santhosh SR, Parida M, Lakshmana Rao PV. RNA interference mediated inhibition of Chikungunya virus replication in mammalian cells. Biochem. Biophys. Res. Commun.376, 718–722 (2008).
  • Thiboutot MM, Kannan S, Kawalekar OU et al. Chikungunya: a potentially emerging epidemic? PLoS Negl. Trop. Dis.4, e623 (2010).
  • Eckels KH, Harrison VR, Hetrick FM. Chikungunya virus vaccine prepared by Tween-ether extraction. Appl. Microbiol.19, 321–325 (1970).
  • Harrison VR, Eckels KH, Bartelloni PJ, Hampton C. Production and evaluation of a formalin-killed Chikungunya vaccine. J. Immunol.107, 643–647 (1971).
  • Levitt NH, Ramsburg HH, Hasty SE et al. Development of an attenuated strain of Chikungunya virus for use in vaccine production. Vaccine4, 157–162 (1986).
  • McClain DJ, Pittman PR, Ramsburg HH et al. Immunologic interference from sequential administration of live attenuated alphavirus vaccines. J. Infect. Dis.177, 634–641 (1998).
  • Edelman R, Tacket CO, Wasserman SS et al. Phase II safety and immunogenicity study of live Chikungunya virus vaccine TSI-GSD-218. Am. J. Trop. Med. Hyg.62, 681–685 (2000).
  • Muthumani K, Lankaraman KM, Laddy DJ et al. Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus. Vaccine26, 5128–5134 (2008).
  • Akahata W, Yang ZY, Andersen H et al. A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection. Nat. Med.16, 334–338

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.